(NasdaqGM:AFCG), WEST PALM BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) — Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC” or the “Company”) announced today that it has completed its previously announced conversion from a real estate investment trust (“REIT”) to a business development company (“BDC”) regulated under the Investment Company Act of 1940, as amended (the […]

(NASDAQ:KURA), SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on January 2, 2026, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards consisting

(NASDAQ:AMCI), NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) — AMC Robotics Corporation (Nasdaq: AMCI) (“AMC Robotics” or the “Company”), an AI-driven robotics solutions company, today announced the establishment of a Vietnamese wholly owned subsidiary with its operations to be located in Ho Chi Minh City, Vietnam, to support the manufacturing and production scale-up of its

(NASDAQ:BBIO), PALO ALTO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that co-founder and CEO, Neil Kumar, Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January

(CNSX:TCEC.CN),(OTC US:TCEFF),(Other OTC:TCEFF),(Boerse Frankfurt – Freiverkehr:C9O0), Vancouver B.C., Jan. 05, 2026 (GLOBE NEWSWIRE) — TERRA CLEAN ENERGY CORP. (“Terra” or the “Company“) (CSE: TCEC, OTCQB: TCEFF, FSE: C9O0) welcomes the recent U.S. Department of Energy announcement on uranium and announces the appointment of Jon Li as Chief Financial Officer of the Company effective January 1,

(NYSE:NVRI), Tom Vadaketh will retire following the Clean Earth sale and spin-off of New Enviri that is expected mid-year Former Enviri CFO, Pete Minan, will bring finance industry experience and deep understanding of Enviri and its Harsco Environmental and Rail businesses PHILADELPHIA, Jan. 05, 2026 (GLOBE NEWSWIRE) — Enviri Corporation (NYSE: NVRI) (“Enviri,” or the

(NYSE MKT:PTHS), Acquisition adds complementary asset to the Pelthos commercial portfolio Xeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age and older DURHAM, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) — Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing

(NASDAQ:MDCX), PHILADELPHIA, Jan. 05, 2026 (GLOBE NEWSWIRE) — Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased to announce that it will present at Biotech Showcase 2026, taking place January 12-14, 2026, in

WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) — ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, today announced the appointment of Christopher Murphy as Chief Executive Officer (CEO) and member of its Board of Directors. He will succeed Ger Brophy, Ph.D., who has served as interim CEO since May 2025,

Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH Alignment on Phase 3 registrational trial parameters confirmed following receipt of minutes from end-of-phase 2 meeting with U.S. FDA GlobeNewswire January 05, 2026 GAITHERSBURG, Md., Jan. 05, 2026 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing therapies that address serious